IBRX
IBRX · Mid Cap · Healthcare · Biotechnology
$8.21−$0.10 (-1.20%)
Market closed · opens in 1d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on IBRX
Free to track. No card required. Usually ready in 10-15 minutes.
Where IBRX sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$1.95
High$12.43
Today $8.21
RSI (14)
27.5Oversold
03070100
Stocksbrew score
60/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$8.21
Lowest
$12
Median target
$14.5
Highest
$16
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Current ratio
Strong · Good liquidity position
5.72x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
58.68x
ROIC
Weak · Weak capital efficiency
-69.1%
How it stacks up against its peers
IBRX against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $9.73B | - | +192.9% | 60 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |
What is moving IBRX
Every story that touched the stock this week, newest first.